CN101756904A - 壳聚糖微球制备工艺 - Google Patents

壳聚糖微球制备工艺 Download PDF

Info

Publication number
CN101756904A
CN101756904A CN200810154879A CN200810154879A CN101756904A CN 101756904 A CN101756904 A CN 101756904A CN 200810154879 A CN200810154879 A CN 200810154879A CN 200810154879 A CN200810154879 A CN 200810154879A CN 101756904 A CN101756904 A CN 101756904A
Authority
CN
China
Prior art keywords
matrine
magnetic
preparation
magnetic fluid
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200810154879A
Other languages
English (en)
Inventor
曹翠珍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN200810154879A priority Critical patent/CN101756904A/zh
Publication of CN101756904A publication Critical patent/CN101756904A/zh
Pending legal-status Critical Current

Links

Abstract

本发明公开了一种苦参碱磁性壳聚糖微球制备工艺,其特征在于应用化学沉淀法制备磁流体,应用离子凝聚法制备苦参碱磁性壳聚糖微球,微球粒径呈正态分布,且分布均匀。制备过程未引入有毒的试剂,未产生不必要的影响。属于医药技术领域。

Description

壳聚糖微球制备工艺
技术领域
本发明涉及苦参碱磁性壳聚糖微球的制备工艺,属于医药技术领域。
背景技术
苦参碱(matrine)是广泛存在于豆科植物苦参,苦豆子及广豆根中的四环喹诺里西啶类生物碱,对肿瘤有抑制作用。
磁靶向给药系统(magnetic targeting drug delivery system,MTDDS)是近年来研究的一类新型靶向药物传递系统,属于第四代给药系统--靶向给药系统,目前国内外研究尚处于起步阶段。该系统系将药物和磁性物质与适当的载体材料制成稳定体系,在一定强度的外磁场作用下,使药物定位于靶区,浓集并释放,从而在病变部位发挥疗效,具有高效、速效、低毒的特点[1]。该系统克服了同一代的脂质体、纳米粒、微球等靶向给药系统的缺点和不足,可以靶向定位释药,很大程度上避免了药物被网状内皮系统(RES)的巨噬细胞吞噬,实现了主动靶向给药,是抗肿瘤治疗的理想剂型。此外,MTDDS还有不易被RES吞噬、载药量大、磁响应性好等优点。作为药物靶向应用的新载体,可采用生物可降解的高分子聚合物如壳聚糖、聚乳酸、白蛋白等作为靶向给药的载体,将药物包裹或嵌入,制备出载药的微球。根据其直径大小不同,可以被肺、肝、肾、脾等截留,从而实现生物物理靶向作用,用于各种实体癌,如肝癌、肺癌、食道癌、胃癌、宫颈癌等的治疗。
发明内容
为了克服现有技术的不足,本发明的目的在于提供一种苦参碱磁性壳聚糖微球制备工艺。
本发明是通过以下技术方案来实现的:苦参碱磁性壳聚糖微球制备工艺,其特征在于包括以下步骤:
磁流体的制备:准确称取0.01mol(2.703g)FeCl3.6H2O,0.005moL(0.995g)FeCl2.4H2O(即摩尔比2∶1),放入500mL三颈烧瓶中,加入200mL二次蒸馏水溶解并水浴加热至40℃,在超声与搅拌条件下滴加新制2moL/L NaOH至pH=11,陈化30min,用注射器在5min内滴入5mL油酸,保温反应2h后用0.5mol/L HCl调节pH=7,用蒸馏水反复冲洗,并以1000r/min的速度离心10min除去较大颗粒,就得到稳定的磁流体。
载药苦参碱磁性微球的制备:分别用醋酸溶液配制4mg/mL壳聚糖溶液,用蒸馏水配制1mg/mL多聚磷酸盐,取壳聚糖溶液10mL,加入0.67mL磁流体和0.1g苦参碱,在1000r/min搅拌下,将5mL多聚磷酸盐注入到壳聚糖溶液中,搅拌、分离、干燥即得载药苦参碱磁性微球。
本发明的有益效果是:本发明采用离子凝聚法制备苦参碱磁性壳聚糖微球,其过程由静电引发物理交联反应,避免在化学交联过程中引入有毒的试剂,未产生不必要的影响,获得的微球具有强靶向,生物可降解性。
附图说明
图1为磁流体粒径和粒径分布图;
图2为磁性微球粒径和粒径分布图
具体实施方式
下面将详细说明本发明的具体实施方式:
1、仪器与试剂:
仪器:D-1型无级调速磁力搅拌器(巩义市英峪予华仪器厂);Zetasizer-3000HSA激光粒度测试仪(英Malvern);TDL-5离心机(上海安亭科学仪器厂)。
试剂
氯化铁(FeCl3.6H2O)、氯化亚铁(FeCl2.6H2O)(天津市大港亿中化工厂,分析纯);壳聚糖(浙江玉环海洋生物公司,Mw90万,脱乙酰度92%),多聚磷酸盐(TPP),双蒸水,其余试剂均为分析纯。
2、实验及结果
磁流体的制备:准确称取0.01mol(2.703g)FeCl3.6H2O,0.005moL(0.995g),FeCl2.4H2O,(即摩尔比2∶1),放入500mL三颈烧瓶中,加入200mL二次蒸馏水溶解并水浴加热至40℃,在超声与搅拌条件下滴加新制2moL/L NaOH至pH=11,陈化30min,用注射器在5min内滴入5mL油酸,保温反应2h后用0.5mol/L HCl调节pH=7,用蒸馏水反复冲洗,并以1000r/min的速度离心10min除去较大颗粒,就得到稳定的磁流体。
载药苦参碱磁性微球的制备:分别用醋酸溶液配制4mg/mL壳聚糖溶液,用蒸馏水配制1mg/mL多聚磷酸盐,取壳聚糖溶液10mL,加入0.67mL磁流体和0.1g苦参碱,在1000r/min搅拌下,将5mL多聚磷酸盐注入到壳聚糖溶液中,搅拌、分离、干燥即得载药苦参碱磁性微球。
取一定量的磁流体和苦参碱磁性壳聚糖微球,超声分散后用Zetasizer 3000HSA激光粒度测试仪测试其粒径及其粒径分布,见图1和图2所示,磁流体的平均粒径为152.2nm,苦参碱磁性微球的平均粒径为682.4nm,粒径呈正态分布,且分布均匀。
以上已以较佳实施例公开了本发明,然其并非用以限制本发明,凡采用等同替换或者等效变换方式所获得的技术方案,均落在本发明的保护范围之内。

Claims (1)

1.苦参碱磁性壳聚糖微球制备工艺,其特征在于包括以下步骤:
(1)磁流体的制备:准确称取0.01mol(2.703g)FeCl3.6H2O,0.005moL(0.995g)FeCl2.4H2O(即摩尔比2∶1),放入500mL三颈烧瓶中,加入200mL二次蒸馏水溶解并水浴加热至40℃,在超声与搅拌条件下滴加新制2moL/L NaOH至pH=11,陈化30min,用注射器在5min内滴入5mL油酸,保温反应2h后用0.5mol/L HCl调节pH=7,用蒸馏水反复冲洗,并以1000r/min的速度离心10min除去较大颗粒,就得到稳定的磁流体;
(2)载药苦参碱磁性微球的制备:分别用醋酸溶液配制4mg/mL壳聚糖溶液,用蒸馏水配制1mg/mL多聚磷酸盐,取壳聚糖溶液10mL,加入0.67mL磁流体和0.1g苦参碱,在1000r/min搅拌下,将5mL多聚磷酸盐注入到壳聚糖溶液中,搅拌、分离、干燥即得载药苦参碱磁性微球。
CN200810154879A 2008-10-27 2008-10-27 壳聚糖微球制备工艺 Pending CN101756904A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810154879A CN101756904A (zh) 2008-10-27 2008-10-27 壳聚糖微球制备工艺

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810154879A CN101756904A (zh) 2008-10-27 2008-10-27 壳聚糖微球制备工艺

Publications (1)

Publication Number Publication Date
CN101756904A true CN101756904A (zh) 2010-06-30

Family

ID=42488390

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810154879A Pending CN101756904A (zh) 2008-10-27 2008-10-27 壳聚糖微球制备工艺

Country Status (1)

Country Link
CN (1) CN101756904A (zh)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104004744A (zh) * 2014-06-12 2014-08-27 江南大学 一种制备具有缓释效果的固定化葡萄糖氧化酶的方法
CN104689374A (zh) * 2015-03-26 2015-06-10 福州大学 一种有机/无机双相杂化靶磁性载中药复合微球
CN104689375A (zh) * 2015-03-26 2015-06-10 福州大学 一种双重原位杂化制备的具有磁响应性多重梯度载药微球

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104004744A (zh) * 2014-06-12 2014-08-27 江南大学 一种制备具有缓释效果的固定化葡萄糖氧化酶的方法
CN104689374A (zh) * 2015-03-26 2015-06-10 福州大学 一种有机/无机双相杂化靶磁性载中药复合微球
CN104689375A (zh) * 2015-03-26 2015-06-10 福州大学 一种双重原位杂化制备的具有磁响应性多重梯度载药微球

Similar Documents

Publication Publication Date Title
Zhang et al. Metal–organic-framework-supported immunostimulatory oligonucleotides for enhanced immune response and imaging
Gao et al. Preparation of anti-CD40 antibody modified magnetic PCL-PEG-PCL microspheres
Ma et al. Cancer theranostic nanoparticles self-assembled from amphiphilic small molecules with equilibrium shift-induced renal clearance
García-Jimeno et al. Magnetoliposomes prepared by reverse-phase followed by sequential extrusion: Characterization and possibilities in the treatment of inflammation
Liang et al. pH‐responsive nanoparticles loaded with graphene quantum dots and doxorubicin for intracellular imaging, drug delivery and efficient cancer therapy
Tang et al. The effect of cryoprotection on the use of PLGA encapsulated iron oxide nanoparticles for magnetic cell labeling
CN103980506B (zh) 一种基于聚乳酸–聚乙二醇嵌段共聚物的磁性微球的制备方法
Zhou et al. Magnetic tumor targeting of β-glucosidase immobilized iron oxide nanoparticles
Chen et al. Study of Fe3O4–PLLA–PEG–PLLA magnetic microspheres based on supercritical CO2: Preparation, physicochemical characterization, and drug loading investigation
Bian et al. Preparation and study on anti-tumor effect of chitosan-coated oleanolic acid liposomes
Tian et al. Paclitaxel-loaded magnetic nanoparticles: synthesis, characterization, and application in targeting
Shen et al. Polyphosphoester-based cationic nanoparticles serendipitously release integral biologically-active components to serve as novel degradable inducible nitric oxide synthase inhibitors
CN101756904A (zh) 壳聚糖微球制备工艺
Sivakumar et al. Chitosan capped nanoscale Fe-MIL-88B-NH2 metal-organic framework as drug carrier material for the pH responsive delivery of doxorubicin
Israel et al. Ultrasound-mediated surface engineering of theranostic magnetic nanoparticles: an effective one-pot functionalization process using mixed polymers for siRNA delivery
Zhu et al. Targeted therapeutic effects of oral magnetically driven pectin nanoparticles containing chlorogenic acid on colon cancer
Nagura et al. Preparation of Robust Metal‐Free Magnetic Nanoemulsions Encapsulating Low‐Molecular‐Weight Nitroxide Radicals and Hydrophobic Drugs Directed Toward MRI‐Visible Targeted Delivery
Chen et al. Preparation and antitumor effect evaluation of composite microparticles co-loaded with siRNA and paclitaxel by a supercritical process
CN101697962A (zh) 苦参碱磁性壳聚糖微球制备工艺
CN100386080C (zh) 汉防己甲素固体脂质纳米粒及其制备方法
CN100362984C (zh) 一种苦参碱磁性微球的制备方法
Alpdemir et al. Magnetically responsive, sorafenib loaded alginate microspheres for hepatocellular carcinoma treatment
CN105434355B (zh) 一种Fe3O4磁性尼莫地平脂质体及其制备方法
Liu et al. Physiochemical properties and paclitaxel release behaviors of dual-stimuli responsive copolymer-magnetite superparamagnetic nanocomposites
Li et al. Micellization of antineoplastic agent to significantly upregulate efficacy and security

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
DD01 Delivery of document by public notice

Addressee: Cao Cuizhen

Document name: Notification of Publication of the Application for Invention

DD01 Delivery of document by public notice

Addressee: Cao Cuizhen

Document name: Notification of before Expiration of Request of Examination as to Substance

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Open date: 20100630